PharmacovigilanceOfficial

Council sets EU position on Faroe Islands veterinary protocol amendments

🇪🇺 EUR-Lex · Fri 30 Oct 2026

The Council has fixed the EU's stance for the Joint Committee under the EU–Denmark/Faroe Islands Agreement, covering changes to provisions implementing the Protocol on veterinary matters.

The Council of the EU has adopted Decision (EU) 2026/2471, dated 12 October 2026, setting the position the Union will take within the Joint Committee established by the Agreement between the European Community and the governments of Denmark and the Faroe Islands. The decision was published in the Official Journal on 30 October 2026.

The Joint Committee will consider an amendment to the provisions that implement the Protocol on veterinary matters, which supplements the Agreement. The Council decision fixes the line that the EU's representatives must follow in that forum.

The text available for this report does not describe the specific amendments. It is therefore not possible to say what practical effect they may have on veterinary medicines, on pharmacovigilance obligations or on trade conditions with the Faroe Islands.

As general context, Council decisions of this kind set the Union's negotiating position in bodies created by international agreements, so that the EU speaks with one voice when those bodies adopt binding changes.

What it means for your team

  • The substance of the amendments is not set out in the material reviewed, so no change to veterinary medicine requirements can be assumed.
  • Teams with veterinary products or supply chains linked to the Faroe Islands should consult the full Decision and any Joint Committee decision once adopted.
  • Watch for the Joint Committee's own decision, which would be the instrument that actually amends the implementing provisions.

Official source: EUR-Lex ↗

Article written by VigiEye from the official source (EUR-Lex). AI-assisted; check the source before acting.

More Pharmacovigilance All →